The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for ...
A ketogenic diet may improve symptoms of depression, according to a new review and meta-analysis published in JAMA Psychiatry ...
The FDA has approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for treating major depressive ...
The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...
Caplyta’s most recent FDA approval is based on positive results from two Phase III clinical trials: Study 501 (NCT04985942) and Study 502 (NCT05061706). Both studies met their primary endpoint and key ...
Depression is one of the most common mental health conditions, and some people recover with medications or therapies. However ...
A powerful collection of books that reveal the inner reality of mental illness with honesty, empathy, and unflinching emotional depth., Books, Times Now ...
Titusville: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved CAPLYTA (lumateperone) as an adjunctive therapy with antidepressants for the treatment ...
ONE-D is the first reported protocol to achieve remission from treatment-resistant depression with a single day of treatment, using an ...
Lady Gaga opened up about filming an Oscar-nominated film on lithium and the "really scary" challenges that followed. "I did ...
Seven years after breakout film role in Bradley Cooper‘s A Star Is Born, Lady Gaga recently recalled a bit of life imitating ...
NRx Pharmaceuticals (NASDAQ: NRXP), announced that its subsidiary, HOPE Therapeutics(TM), has initiated patient care using the Ampa "one day" (ONE-D) protocol for treatment-resistant depression - ...